The explosive rise of GLP-1 weight loss drugs such as Ozempic and Wegovy could deliver an unexpected windfall for the airline industry. According to a new study by Wall Street firm Jefferies, lighter passengers could translate into significantly lower fuel consumption, saving major U.S. airlines an estimated $580 million annually. Fuel is the single largest … Continue reading GLP-1 Weight Loss Drugs Could Save Airlines $580 Million a Year in Fuel Costs, Study Finds